Mast cells and the liver aging process

Immunity and Ageing

Volumn 10, Issue 1, 2013, Pages

  Grizzi, Fabio ^a   Di Caro, Giuseppe ^a   Laghi, Luigi ^a   Hermonat, Paul ^b   Mazzola, Paolo ^c   Nguyen, Diane D ^d   Radhi, Saba ^d   Figueroa, Jose A ^d   Cobos, Everardo ^d,e   Annoni, Giorgio ^c   Chiriva Internati, Maurizio ^d,e  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c SAN GERARDO HOSPITAL   (Italy)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^e TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Ageing; Immune system; Immunosenescence; Inflammation; Liver; Mast cells

Indexed keywords

AGING; CELL POPULATION; DENDRITIC CELL; HISTOPATHOLOGY; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LIVER; LIVER DISEASE; LIVER FUNCTION; LIVER REGENERATION; MACROPHAGE; MAST CELL; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 84874602058     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/1742-4933-10-9     Document Type: Review

References (128)

1. Meyer KC. Aging. Proc Am Thorac Soc 2005, 2:433-439. 10.1513/pats.200508-081JS, 16322596.
2. Troen BR. The biology of aging. Mt Sinai J Med 2003, 70:3-22.
3. Anantharaju A, Feller A, Chedid A. Aging Liver. a review. Gerontology 2002, 48:343-353. 10.1159/000065506, 12393949.
4. Hayflick L. The biology of human aging. Plast Reconstr Surg 1981, 67:536-550. 10.1097/00006534-198104000-00023, 7010399.
5. Ottaviani E, Malagoli D, Capri M, Franceschi C. Ecoimmunology: is there any room for the neuroendocrine system?. Bioessays 2008, 30:868-874. 10.1002/bies.20801, 18693265.
6. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993, 23:2375-2378. 10.1002/eji.1830230950, 8370415.
7. Vescovini R, Telera A, Fagnoni FF, Biasini C, Medici MC, Valcavi P, di Pede P, Lucchini G, Zanlari L, Passeri G. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells. Exp Gerontol 2004, 39:1233-1243. 10.1016/j.exger.2004.04.004, 15288697.
8. Pawelec G. Hallmarks of human "immunosenescence": adaptation or dysregulation?. Immun Ageing 2012, 9:15. 10.1186/1742-4933-9-15, 3416738, 22830639.
9. Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G. Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 2008, 23:64-74.
10. Junaidi O, Di Bisceglie AM. Aging liver and hepatitis. Clin Geriatr Med 2007, 23:889-903. viii, 10.1016/j.cger.2007.06.006, 17923344.
11. Floreani A. Liver diseases in the elderly: an update. Dig Dis 2007, 25:138-143. 10.1159/000099478, 17468549.
12. Gorczynski RM, Terzioglu E. Aging and the immune system. Int Urol Nephrol 2008, 40:1117-1125. 10.1007/s11255-008-9412-1, 18683074.
13. Shurin MR, Shurin GV, Chatta GS. Aging and the dendritic cell system: implications for cancer. Crit Rev Oncol Hematol 2007, 64:90-105. 10.1016/j.critrevonc.2007.03.002, 2084365, 17446082.
14. Wick G, Grubeck-Loebenstein B. Immunity and aging. Dev Comp Immunol 1997, 21:455-460. 10.1016/S0145-305X(97)00025-6, 9463778.
15. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000, 31:578-585. 10.1086/313947, 10987724.
16. Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B. Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 2008, 46:1078-1084. 10.1086/529197, 18444828.
17. Miller RA. The aging immune system: primer and prospectus. Science 1996, 273:70-74. 10.1126/science.273.5271.70, 8658199.
18. Grubeck-Loebenstein B. Changes in the aging immune system. Biologicals 1997, 25:205-208. 10.1006/biol.1997.0085, 9236053.
19. Appay V, Sauce D, Prelog M. The role of the thymus in immunosenescence: lessons from the study of thymectomized individuals. Aging (Albany NY) 2010, 2:78-81.
20. Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol 2007, 211:144-156. 10.1002/path.2104, 1931833, 17200946.
21. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ. Aging and innate immune cells. J Leukoc Biol 2004, 76:291-299. 10.1189/jlb.1103592, 15039467.
22. Derhovanessian E, Solana R, Larbi A, Pawelec G. Immunity, ageing and cancer. Immun Ageing 2008, 5:11. 10.1186/1742-4933-5-11, 2564902, 18816370.
23. Mazzola P, Radhi S, Mirandola L, Annoni G, Jenkins M, Cobos E, Chiriva-Internati M. Aging, cancer, and cancer vaccines. Immun Ageing 2012, 9:4. 10.1186/1742-4933-9-4, 3353870, 22510392.
24. Lee JB, Oelke M, Ramachandra L, Canaday DH, Schneck JP. Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors. Immun Ageing 2011, 8:6. 10.1186/1742-4933-8-6, 3179433, 21846352.
25. Provinciali M, Barucca A, Cardelli M, Marchegiani F, Pierpaoli E. Inflammation, aging, and cancer vaccines. Biogerontology 2010, 11:615-626. 10.1007/s10522-010-9280-9, 20455022.
26. Hodes RJ. The effects of aging on lymphocyte development and function: introduction. Springer Semin Immunopathol 2002, 24:1-5. 10.1007/s00281-001-0091-6, 11974578.
27. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000, 908:244-254.
28. Franceschi C, Valensin S, Bonafe M, Paolisso G, Yashin AI, Monti D, De Benedictis G. The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol 2000, 35:879-896. 10.1016/S0531-5565(00)00172-8, 11053678.
29. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 2005, 579:2035-2039. 10.1016/j.febslet.2005.02.055, 15811314.
30. Macaulay R, Akbar AN, Henson SM. The role of the T cell in age-related inflammation. Age (Dordr) 2012,
31. Ginaldi L, De Martinis M, Monti D, Franceschi C. The immune system in the elderly: activation-induced and damage-induced apoptosis. Immunol Res 2004, 30:81-94. 10.1385/IR:30:1:081, 15258312.
32. Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A. Human immunosenescence: is it infectious?. Immunol Rev 2005, 205:257-268. 10.1111/j.0105-2896.2005.00271.x, 15882359.
33. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 2001, 8:131-136. 10.1097/00062752-200105000-00001, 11303144.
34. Crighton MH, Puppione AA. Geriatric neutrophils: implications for older adults. Semin Oncol Nurs 2006, 22:3-9. 10.1016/j.soncn.2005.10.002, 16458177.
35. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006, 80:219-227. 10.1016/j.yexmp.2005.11.004, 16460728.
36. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev 2011, 10:319-329. 10.1016/j.arr.2010.11.002, 3098911, 21145432.
37. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004, 39:687-699. 10.1016/j.exger.2004.01.009, 15130663.
38. Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res 2008, 659:15-30. 10.1016/j.mrrev.2008.03.002, 18485806.
39. Hoare M, Das T, Alexander G. Ageing, telomeres, senescence, and liver injury. J Hepatol 2010, 53:950-961. 10.1016/j.jhep.2010.06.009, 20739078.
40. Schmucker DL. Age-related changes in liver structure and function: Implications for disease ?. Exp Gerontol 2005, 40:650-659. 10.1016/j.exger.2005.06.009, 16102930.
41. Le Couteur DG, Warren A, Cogger VC, Smedsrod B, Sorensen KK, De Cabo R, Fraser R, McCuskey RS. Old age and the hepatic sinusoid. Anat Rec (Hoboken) 2008, 291:672-683.
42. Woodhouse KW, James OF. Hepatic drug metabolism and ageing. Br Med Bull 1990, 46:22-35.
43. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989, 9:297-301. 10.1002/hep.1840090222, 2643548.
44. Iber FL, Murphy PA, Connor ES. Age-related changes in the gastrointestinal system. Effects on drug therapy. Drugs Aging 1994, 5:34-48. 10.2165/00002512-199405010-00004, 7919638.
45. Zoli M, Magalotti D, Bianchi G, Gueli C, Orlandini C, Grimaldi M, Marchesini G. Total and functional hepatic blood flow decrease in parallel with ageing. Age Ageing 1999, 28:29-33. 10.1093/ageing/28.1.29, 10203201.
46. Schmucker DL. Aging and the liver: an update. J Gerontol A Biol Sci Med Sci 1998, 53:B315-320.
47. Kudryavtsev BN, Kudryavtseva MV, Sakuta GA, Stein GI. Human hepatocyte polyploidization kinetics in the course of life cycle. Virchows Arch B Cell Pathol Incl Mol Pathol 1993, 64:387-393. 10.1007/BF02915139, 8148960.
48. Schmucker DL, Sanchez H. Liver regeneration and aging: a current perspective. Curr Gerontol Geriatr Res 2011, 2011:526379. 3170699, 21912543.
49. McLachlan AJ, Pont LG. Drug metabolism in older people-a key consideration in achieving optimal outcomes with medicines. J Gerontol A Biol Sci Med Sci 2012, 67:175-180.
50. Shi S, Klotz U. Age-related changes in pharmacokinetics. Curr Drug Metab 2011, 12:601-610. 10.2174/138920011796504527, 21495970.
51. Kwekel JC, Desai VG, Moland CL, Branham WS, Fuscoe JC. Age and sex dependent changes in liver gene expression during the life cycle of the rat. BMC Genomics 2010, 11:675. 10.1186/1471-2164-11-675, 3012673, 21118493.
52. Corsonello A, Pedone C, Incalzi RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 2010, 17:571-584. 10.2174/092986710790416326, 20015034.
53. Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 2009, 41:67-76. 10.1080/03602530902722679, 19514965.
54. Le Couteur DG, McLean AJ. The aging liver. Clin Pharmacokinet. Drug clearance and an oxygen diffusion barrier hypothesis 1998, 34:359-373.
55. Ito Y, Sorensen KK, Bethea NW, Svistounov D, McCuskey MK, Smedsrod BH, McCuskey RS. Age-related changes in the hepatic microcirculation in mice. Exp Gerontol 2007, 42:789-797. 10.1016/j.exger.2007.04.008, 2003050, 17582718.
56. Warren A, Chaberek S, Ostrowski K, Cogger VC, Hilmer SN, McCuskey RS, Fraser R, Le Couteur DG. Effects of old age on vascular complexity and dispersion of the hepatic sinusoidal network. Microcirculation 2008, 15:191-202. 10.1080/10739680701600856, 3081854, 18386215.
57. Le Couteur DG, Cogger VC, Markus AM, Harvey PJ, Yin ZL, Ansselin AD, McLean AJ. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology 2001, 33:537-543. 10.1053/jhep.2001.22754, 11230732.
58. Bhutto A, Morley JE. The clinical significance of gastrointestinal changes with aging. Curr Opin Clin Nutr Metab Care 2008, 11:651-660. 10.1097/MCO.0b013e32830b5d37, 18685464.
59. Cao SX, Dhahbi JM, Mote PL, Spindler SR. Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice. Proc Natl Acad Sci U S A 2001, 98:10630-10635. 10.1073/pnas.191313598, 58517, 11535822.
60. Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, part I: History, examination, body composition, and screening tools. Nutrition 2000, 16:50-63. 10.1016/S0899-9007(99)00224-5, 10674236.
61. Forbes A, Williams R. Increasing age-an important adverse prognostic factor in hepatitis A virus infection. J R Coll Physicians Lond 1988, 22:237-239.
62. Forbes A, Williams R. Changing epidemiology and clinical aspects of hepatitis A. Br Med Bull 1990, 46:303-318.
63. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997, 349:825-832. 10.1016/S0140-6736(96)07642-8, 9121257.
64. Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, Myers RP, Muntenau M, Ratziu V, Manns M. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003, 38:257-265.
65. Hartmann D, Srivastava U, Thaler M, Kleinhans KN, N'Kontchou G, Scheffold A, Bauer K, Kratzer RF, Kloos N, Katz SF. Telomerase gene mutations are associated with cirrhosis formation. Hepatology 2011, 53:1608-1617. 10.1002/hep.24217, 21520174.
66. Goudie BM, Burt AD, Macfarlane GJ, Boyle P, Gillis CR, MacSween RN, Watkinson G. Risk factors and prognosis in primary biliary cirrhosis. Am J Gastroenterol 1989, 84:713-716.
67. Sasaki M, Ikeda H, Yamaguchi J, Nakada S, Nakanuma Y. Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence. Hepatology 2008, 48:186-195. 10.1002/hep.22348, 18536059.
68. Kanda K, Onji M, Ohta Y. Spontaneous occurrence of autoimmune cholangitis in senescent mice. J Gastroenterol Hepatol 1993, 8:7-14. 10.1111/j.1440-1746.1993.tb01168.x, 8439666.
69. Serrano M. Cancer: final act of senescence. Nature 2011, 479:481-482. 10.1038/479481a, 22113687.
70. Fujishima T, Ishikawa T, Shiratori Y, Kanda M, Tateishi R, Akamatsu M, Koike Y, Sato S, Obi S, Hamamura K. Age-related comparison of the profiles of patients with hepatocellular carcinoma. Hepatogastroenterology 2006, 53:913-918.
71. Youssef JA, Badr MZ. Aging and enhanced hepatocarcinogenicity by peroxisome proliferator-activated receptor alpha agonists. Ageing Res Rev 2005, 4:103-118. 10.1016/j.arr.2004.10.002, 15619473.
72. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev 2002, 66(3):407-425. table of contents, 10.1128/MMBR.66.3.407-425.2002, 120798, 12208997.
73. Lechel A, Manns MP, Rudolph KL. Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma. J Hepatol 2004, 41:491-497. 10.1016/j.jhep.2004.06.010, 15336455.
74. Satyanarayana A, Manns MP, Rudolph KL. Telomeres and telomerase: a dual role in hepatocarcinogenesis. Hepatology 2004, 40:276-283. 10.1002/hep.20308, 15368430.
75. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352. 10.1126/science.279.5349.349, 9454332.
76. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003, 361:393-395. 10.1016/S0140-6736(03)12384-7, 12573379.
77. Kitada T, Seki S, Kawakita N, Kuroki T, Monna T. Telomere shortening in chronic liver diseases. Biochem Biophys Res Commun 1995, 211:33-39. 10.1006/bbrc.1995.1774, 7779103.
78. Urabe Y, Nouso K, Higashi T, Nakatsukasa H, Hino N, Ashida K, Kinugasa N, Yoshida K, Uematsu S, Tsuji T. Telomere length in human liver diseases. Liver 1996, 16:293-297. 10.1055/s-2007-1007242, 8938628.
79. Metcalfe DD, Lewis RA, Silbert JE, Rosenberg RD, Wasserman SI, Austen KF. Isolation and characterization of heparin from human lung. J Clin Invest 1979, 64:1537-1543. 10.1172/JCI109613, 371305, 500822.
80. Metcalfe DD. Mast cells and mastocytosis. Blood 2008, 112:946-956. 10.1182/blood-2007-11-078097, 2515131, 18684881.
81. Francis H, Meininger CJ. A review of mast cells and liver disease: What have we learned?. Dig Liver Dis 2010, 42:529-536. 10.1016/j.dld.2010.02.016, 20363674.
82. Metz M, Maurer M. Mast cells-key effector cells in immune responses. Trends Immunol 2007, 28:234-241. 10.1016/j.it.2007.03.003, 17400512.
83. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008, 8:478-486. 10.1038/nri2327, 2855166, 18483499.
84. Bradding P. Human mast cell cytokines. Clin Exp Allergy 1996, 26:13-19. 10.1111/j.1365-2222.1996.tb00051.x, 8789538.
85. Kruger-Krasagakes S, Czarnetzki BM. Cytokine secretion by human mast cells. Exp Dermatol 1995, 4:250-254. 10.1111/j.1600-0625.1995.tb00253.x, 8528597.
86. Gruber BL. Mast cells in the pathogenesis of fibrosis. Curr Rheumatol Rep 2003, 5:147-153. 10.1007/s11926-003-0043-3, 12628046.
87. Franceschini B, Ceva-Grimaldi G, Russo C, Dioguardi N, Grizzi F. The complex functions of mast cells in chronic human liver diseases. Dig Dis Sci 2006, 51:2248-2256. 10.1007/s10620-006-9082-8, 17103041.
88. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 1997, 61:233-245.
89. Persinger MA, Lepage P, Simard JP, Parker GH. Mast cell numbers in incisional wounds in rat skin as a function of distance, time and treatment. Br J Dermatol 1983, 108:179-187. 10.1111/j.1365-2133.1983.tb00060.x, 6824575.
90. Grizzi F, Franceschini B, Chiriva-Internati M, Liu Y, Hermonat PL, Dioguardi N. Mast cells and human hepatocellular carcinoma. World J Gastroenterol 2003, 9:1469-1473.
91. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006, 43:S54-62. 10.1002/hep.21060, 16447271.
92. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990, 346:274-276. 10.1038/346274a0, 2374592.
93. Bradding P. Human lung mast cell heterogeneity. Thorax 2009, 64:278-280. 10.1136/thx.2008.106427, 19329727.
94. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004, 114:174-182. 10.1016/j.jaci.2004.03.049, 15241362.
95. Gagliano N, Grizzi F, Annoni G. Mechanisms of aging and liver functions. Dig Dis 2007, 25:118-123. 10.1159/000099475, 17468546.
96. Krishnaswamy G, Kelley J, Johnson D, Youngberg G, Stone W, Huang SK, Bieber J, Chi DS. The human mast cell: functions in physiology and disease. Front Biosci 2001, 6:D1109-1127. 10.2741/krishnas, 11532608.
97. Abd-El-Aleem SA, Morgan C, Ferguson MW, McCollum CN, Ireland GW. Spatial distribution of mast cells in chronic venous leg ulcers. Eur J Histochem 2005, 49:265-272.
98. Yu M, Tsai M, Tam SY, Jones C, Zehnder J, Galli SJ. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 2006, 116:1633-1641. 10.1172/JCI25702, 1462940, 16710480.
99. Sankovic S, Dergenc R, Bojic P. Mast cells in chronic inflammation of the middle ear mucosa. Rev Laryngol Otol Rhinol (Bord) 2005, 126:15-18.
100. Nguyen M, Pace AJ, Koller BH. Age-induced reprogramming of mast cell degranulation. J Immunol 2005, 175:5701-5707.
101. Gittlen SD, Schulman ES, Maddrey WC. Raised histamine concentrations in chronic cholestatic liver disease. Gut 1990, 31:96-99. 10.1136/gut.31.1.96, 1378348, 2108078.
102. Tsuneyama K, Saito K, Ruebner BH, Konishi I, Nakanuma Y, Gershwin ME. Immunological similarities between primary sclerosing cholangitis and chronic sclerosing sialadenitis: report of the overlapping of these two autoimmune diseases. Dig Dis Sci 2000, 45:366-372. 10.1023/A:1005429130150, 10711453.
103. Koruk ST, Ozardali I, Dincoglu D, Bitiren M. Increased liver mast cells in patients with chronic hepatitis C. Indian J Pathol Microbiol 2011, 54:736-740.
104. Meier P, Seitz HK. Age, alcohol metabolism and liver disease. Curr Opin Clin Nutr Metab Care 2008, 11:21-26. 10.1097/MCO.0b013e3282f30564, 18090653.
105. Faught E. Monotherapy in adults and elderly persons. Neurology 2007, 69:S3-9. 10.1212/01.wnl.0000302370.01359.8f, 18071156.
106. Amador-Noguez D, Dean A, Huang W, Setchell K, Moore D, Darlington G. Alterations in xenobiotic metabolism in the long-lived Little mice. Aging Cell 2007, 6:453-470. 10.1111/j.1474-9726.2007.00300.x, 2859448, 17521389.
107. Ritz P, Vellas B. Pharmacokinetics and drug toxicity in elderly patients: a case for geriatric core data in clinical trials. J Nutr Health Aging 2007, 11:261-264.
108. Zeeh J. The aging liver: consequences for drug treatment in old age. Arch Gerontol Geriatr 2001, 32:255-263. 10.1016/S0167-4943(01)00090-5, 11395171.
109. Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf 2004, 3:485-493. 10.1517/14740338.3.5.485, 15335303.
110. McLean AJ, Cogger VC, Chong GC, Warren A, Markus AM, Dahlstrom JE, Le Couteur DG. Age-related pseudocapillarization of the human liver. J Pathol 2003, 200:112-117. 10.1002/path.1328, 12692849.
111. Warren A, Bertolino P, Cogger VC, McLean AJ, Fraser R, Le Couteur DG. Hepatic pseudocapillarization in aged mice. Exp Gerontol 2005, 40:807-812. 10.1016/j.exger.2005.06.012, 16125353.
112. Cogger VC, Warren A, Fraser R, Ngu M, McLean AJ, Le Couteur DG. Hepatic sinusoidal pseudocapillarization with aging in the non-human primate. Exp Gerontol 2003, 38:1101-1107. 10.1016/j.exger.2003.07.002, 14580863.
113. Deleve LD, Wang X, Guo Y. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology 2008, 48:920-930. 10.1002/hep.22351, 2695448, 18613151.
114. Inada N, Shoji J, Tabuchi K, Saito K, Sawa M. Histological study on mast cells in conjunctiva of NC/Nga mice. Jpn J Ophthalmol 2004, 48:189-194. 10.1007/s10384-003-0048-5, 15175908.
115. Moron G, Maletto B, Orsilles M, Depiante-Depaoli M, Pistoresi-Palencia MC. Age-related alterations in inflammatory response during experimental autoimmune prostatitis. Mech Ageing Dev 2000, 118:71-85. 10.1016/S0047-6374(00)00159-7, 10989126.
116. Ceballos D, Cuadras J, Verdu E, Navarro X. Morphometric and ultrastructural changes with ageing in mouse peripheral nerve. J Anat 1999, 195:563-576. 10.1046/j.1469-7580.1999.19540563.x, 1468027, 10634695.
117. Ahlstedt S, Haard J. Age-dependent bone marrow mast cell maturation in specific pathogen-free rats. Int Arch Allergy Appl Immunol 1987, 84:359-362. 10.1159/000234450, 3679563.
118. Chan CL, Jones RL, Lau HY. Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells. Br J Pharmacol 2000, 129:589-597. 10.1038/sj.bjp.0703072, 1571858, 10711359.
119. Hogaboam CM, Bissonnette EY, Chin BC, Befus AD, Wallace JL. Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology 1993, 104:122-129.
120. Mahay S, Pariente JA, Lajas AI, Adeghate E, Rolph CE, Singh J. Effects of ageing on morphology, amylase release, cytosolic Ca2+ signals and acyl lipids in isolated rat parotid gland tissue. Mol Cell Biochem 2004, 266:199-208.
121. Grizzi F, Franceschini B, Barbieri B, Gagliano N, Arosio B, Chiriva-Internati M, Annoni G, Dioguardi N. Mast cell density: a quantitative index of acute liver inflammation. Anal Quant Cytol Histol 2002, 24:63-69.
122. Grizzi F, Franceschini B, Gagliano N, Moscheni C, Annoni G, Vergani C, Hermonat PL, Chiriva-Internati M, Dioguardi N. Mast cell density, hepatic stellate cell activation and TGF-beta1 transcripts in the aging Sprague-Dawley rat during early acute liver injury. Toxicol Pathol 2003, 31:173-178.
123. Dufour E, Larsson NG. Understanding aging: revealing order out of chaos. Biochim Biophys Acta 2004, 1658:122-132. 10.1016/j.bbabio.2004.04.020, 15282183.
124. Xue H, Xian B, Dong D, Xia K, Zhu S, Zhang Z, Hou L, Zhang Q, Zhang Y, Han JD. A modular network model of aging. Mol Syst Biol 2007, 3:147. 2174624, 18059442.
125. Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, Telera A, Lucchini G, Passeri G, Monti D. The immune system in extreme longevity. Exp Gerontol 2008, 43:61-65. 10.1016/j.exger.2007.06.008, 17870272.
126. Zeeh J, Platt D. The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 2002, 48:121-127. 10.1159/000052829, 11961363.
127. Jansen PL. Liver disease in the elderly. Best Pract Res Clin Gastroenterol 2002, 16:149-158. 10.1053/bega.2002.0271, 11977934.
128. Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat Immunol 2008, 9:1215-1223. 10.1038/ni.f.216, 2856637, 18936782.